Consolidated Statements of Changes in Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Noncontrolling Interest	Total
Beginning balance at Dec. 31, 2021	$ 264	$ 393,644	$ (308,733)		$ 85,175
Beginning balance, shares at Dec. 31, 2021	26,395
Share-based awards and options exercises	$ 9	289			298
Share-based awards and options exercises (in shares)	873
Share-based compensation expense		8,746			8,746
Net loss			(37,159)		(37,159)
Ending balance at Dec. 31, 2022	$ 273	402,679	(345,892)		57,060
Ending balance, shares at Dec. 31, 2022	27,268
Share-based awards and options exercises	$ 18	(18)
Share-based awards and options exercises (in shares)	1,824
Share-based compensation expense		7,319			7,319
Net loss			(30,189)		(30,189)
Ending balance at Dec. 31, 2023	$ 291	409,980	(376,081)		34,190
Ending balance, shares at Dec. 31, 2023	29,092
Share-based awards and options exercises	$ 13	(13)
Share-based awards and options exercises (in shares)	1,282
Issuance of warrants, net of issuance costs of $49		2,521			2,521
Issuance of stock as purchase consideration in connection with acquisition	$ 253	28,848		$ 4,112	33,213
Issuance of stock as purchase consideration in connection with acquisition (in shares)	25,305
Share-based compensation expense		5,602			5,602
Net loss			(43,708)	(19)	(43,727)
Ending balance at Dec. 31, 2024	$ 557	$ 446,938	$ (419,789)	$ 4,093	$ 31,799
Ending balance, shares at Dec. 31, 2024	55,679